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Abstract
Ciguatoxins and brevetoxins are neurotoxic cyclic polyether compounds produced by dinoflagellates, which are responsible
for ciguatera and neurotoxic shellfish poisoning (NSP) respectively. Recently, brevenal, a natural compound was found to
specifically inhibit brevetoxin action and to have a beneficial effect in NSP. Considering that brevetoxin and ciguatoxin
specifically activate voltage-sensitive Na
+ channels through the same binding site, brevenal has therefore a good potential
for the treatment of ciguatera. Pacific ciguatoxin-1B (P-CTX-1B) activates voltage-sensitive Na
+ channels and promotes an
increase in neurotransmitter release believed to underpin the symptoms associated with ciguatera. However, the
mechanism through which slow Na
+ influx promotes neurosecretion is not fully understood. In the present study, we used
chromaffin cells as a model to reconstitute the sequence of events culminating in ciguatoxin-evoked neurosecretion. We
show that P-CTX-1B induces a tetrodotoxin-sensitive rise in intracellular Na
+, closely followed by an increase in cytosolic
Ca
2+ responsible for promoting SNARE-dependent catecholamine secretion. Our results reveal that brevenal and b-
naphtoyl-brevetoxin prevent P-CTX-1B secretagogue activity without affecting nicotine or barium-induced catecholamine
secretion. Brevenal is therefore a potent inhibitor of ciguatoxin-induced neurotoxic effect and a potential treatment for
ciguatera.
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Introduction
Ciguatera is the most widespread human syndrome of marine
poisoning that occurs following consumption of fish from tropical
and subtropical pacific regions contaminated with ciguatoxins that
accumulate through the marine food chain [1]. It is mainly
characterised by neurological, gastrointestinal and cardiovascular
disturbances [2]. Ciguatera is a significant public heath issue in
endemic areas with up to 50,000 cases recorded annually [3].
Importantly, it is becoming a widespread health problem with the
globalisation of the fishing industry importing ciguateric fish from
endemic regions [3]. No specific treatment other than symptom-
atic treatment is currently available for this disease. Interestingly,
research with the toxic dinoflagellate that produces brevetoxins,
Karenia brevis, has resulted in the discovery of natural and
chemically modified compounds that may have the potential for
the treatment of ciguatera.
Ciguatoxins and brevetoxins are lipid-soluble cyclic polyether
compounds produced by the benthic dinoflagellates Gambierdiscus
toxicus and Karenia brevis, respectively, which bind competitively to the
receptor-site 5 of voltage-sensitive Na
+ channels [4,5,6]. One of the
well-established consequences of ciguatoxins’ action is an increase in
membrane Na
+ permeability and excitability of most excitable cells
[7]. In particular, Pacific ciguatoxin-1B (P-CTX-1B previously called
CTXandCTX-1b)hasbeenshowntoenhancevoltage-sensitiveNa
+
channels activity by shifting their activation to more negative
membrane potentials, and by inhibiting in part their inactivation
[8]. At the frog neuromuscular junction, P-CTX-1B was reported to
induce repetitive endplate potentials that elicit repetitive muscle
action potentials. In addition, this toxin causes a dramatic increase in
asynchronous acetylcholine release and impairs synaptic vesicle
recycling [9]. These effects are believed to play an important role in
the development of ciguatera disease [10]. Very little is known about
how Na
+ channel activation leads to asynchronous quantal
spontaneous release. One of the possible hypotheses is that
ciguatoxins promote Ca
2+ entry in nerve terminals, which could in
turn stimulate exocytosis. Importantly, the activation of Na
+ channels
by P-CTX-1B has been shown to lead to direct mobilisation of Ca
2+
from internal stores in neuroblastoma cells and rat myotubes [11,12]
and to an indirect activation of the Na
+/Ca
2+ exchanger in the
reversed mode in cholinergic synaptosomes, allowing Ca
2+ influx
against Na
+ efflux [13].
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3448In this study, we have clarified the role played by ciguatoxin-
induced long lasting Na
+ influx in promoting Ca
2+-dependent
neuroexocytosis, by assessing the effect of P-CTX-1B on
neuroendocrine cells. Chromaffin cells are a convenient model
to study both Ca
2+ and Na
+ signalling together with catecholamine
release [14]. Having reconstituted the sequence of events leading
to neuronal secretion, we used newly-developed competitive
inhibitors of brevetoxin to test whether they were able to prevent
ciguatoxin-induced secretagogue activity. We found that both
brevenal and b-naphtoyl-brevetoxin are potent inhibitors of P-
CTX-1B-induced catecholamine secretion without affecting the
response to other secretagogues.
Results
P-CTX-1B promotes a slow cytosolic Na
+ increase in
chromaffin cells
One plausible consequence of P-CTX-1B activation of voltage-
sensitive Na
+ channels and membrane depolarization would be a
marked increase in intracellular Na
+. One way to verify this
possibility was to measure cytosolic Na
+ changes induced by P-
CTX-1B. Intracellular Na
+ was monitored in chromaffin cells pre-
loaded with the cell-permeant Na
+-indicator sodium green.
Experiments were performed in a Ca
2+-free medium containing
EGTA (2 mM) to avoid activation of the Na
+/Ca
2+ exchanger
[13]. Exposure of sodium green loaded chromaffin cells to P-
CTX-1B (50 nM) resulted in a slow albeit significant increase in
intracellular fluorescence intensity that steadily developed contin-
uously for more than 60 min (Figure 1A, B). Under control
conditions, the distribution of the fluorescence intensity seemed
uniform throughout the cells. Following P-CTX-1B exposure, a
slow fluorescence increase was detected throughout the cytoplasm
(Figure 1A). The Na
+ channel blocker tetrodotoxin (TTX, 1 mM)
potently inhibited P-CTX-1B-evoked Na
+ increase (Figure 1C),
indicating that voltage-sensitive Na
+ channel activation is directly
involved in this increase. Taken together, these results indicate that
P-CTX-1B induced a marked rise of cytosolic Na
+ in chromaffin
cells through an activation of voltage-sensitive Na
+ channels.
P-CTX-1B elicits an increase in intracellular Ca
2+ in
chromaffin cells
We next examined whether such long lasting rise in cytosolic
Na
+ could affect intracellular Ca
2+ level. Confocal microscopy was
used to monitor cytosolic Ca
2+ in bovine chromaffin cells pre-
loaded with the cell-permeant Ca
2+ dye fluo-3/AM. In the
presence of 2 mM Ca
2+, exposure of chromaffin cells to P-CTX-
1B (10 nM) resulted in a transient increase in intracellular
fluorescence intensity (Figure 2A) followed by a partial recovery
during which the fluorescence signal remained higher than the
control initial level (Figure 2B, black curve). Interestingly, in the
presence of P-CTX-1B, the fluorescence intensity was higher in a
localised intracellular region of the cell likely to emanate from the
endoplasmic reticulum (ER) (Figure 2A). In the absence of external
Ca
2+, P-CTX-1B was still capable of inducing an increase in
fluorescence intensity, but this increase was transitory and
returned to basal level (Figure 2B, red curve). These results
strongly suggest that at least part of the Ca
2+ rise elicited by P-
CTX-1B originated from intracellular Ca
2+ stores [14]. Chromaf-
fin cells pre-treatment with TTX (1 mM for 15 min) prevented P-
CTX-1B-induced Ca
2+ influx in a Ca
2+-containing medium
(Figure 2C). Importantly, the same cell was still responsive to
high potassium-induced depolarisation known to activate voltage-
gated Ca
2+ channels (Figure 2D). Taken together, these data
indicate that, in bovine chromaffin cells, the P-CTX-1B-induced
activation of voltage-sensitive Na
+ channels produces a TTX-
sensitive increase in intracellular Ca
2+ due to both influx of Ca
2+
into cells and release of Ca
2+ from internal stores.
P-CTX-1B triggers Ca
2+-dependent catecholamine release
Having demonstrated that P-CTX-1B promotes a significant
Ca
2+ mobilisation in neurosecretory cells, our next step was to
investigate whether this signal could be responsible for triggering
neuronal secretion. Addition of P-CTX-1B (10 nM) to chromaffin
cells in the presence of 2 mM external Ca
2+ promotes significant
catecholamine secretion (Figure 3A). This effect was blocked in the
absence of external Ca
2+ (Figure 3A), indicating that external Ca
2+
is necessary for P-CTX-1B-induced catecholamine release. The
maximal secretion was observed 30 min after P-CTX-1B addition
to the medium, indicating that the toxin is a potent albeit relatively
slow-acting secretagogue. Concentration-dependency experiments
show that the Ca
2+-dependent effect was maximal at 50 nM
(Figure 3B). Finally, TTX (1 mM) pre-incubation blocked P-CTX-
1B-induced catecholamine release (Figure 3C), further demon-
strating that Na
+ influx through voltage-sensitive Na
+ channels
was responsible for initiating the secretory effect. Taken together,
these data strongly suggest that the activation of voltage-sensitive
Na
+ channels by P-CTX-1B leads to a long-lasting cytoplasmic
Ca
2+ rise, which, in turn, promotes catecholamine release - an
effect strictly dependent on the presence of external Ca
2+.
P-CTX-1B induces soluble N-ethylmaleimide sensitive
factor attachment protein receptor (SNARE)-dependent
catecholamine release
To exclude the possibility that cell lysis could promote non-
specific catecholamine leakage, we checked whether the release of
catecholamine was sensitive to the cleavage of synaptosomal-
associated protein of molecular weight 25K (SNAP-25) by
Botulinum neurotoxin type-A (BoNT/A). Cultured bovine
chromaffin cells were treated in vitro by clostridial neurotoxins,
using a low ionic strength medium to enable the BoNT
internalization for 24 hours [14,15]. BoNT/A targets and cleaves
the synaptosomal-associated protein of molecular weight 25K
(SNAP-25), a protein associated predominantly with the plasma
membrane, and which is implicated, together with syntaxin and
the vesicular protein VAMP/synaptobrevin, in the fusion
machinery of catecholamine-containing large dense core granules
[16,17]. Chromaffin cells were washed and subjected to P-CTX-
1B in a Ca
2+-containing medium (2 mM). The catecholamine
secretion observed with P-CTX-1B was strongly inhibited by
BoNT/A pre-treatment (Figure 4). This result confirmed that the
P-CTX-1B-evoked catecholamine secretion occurs through a
SNARE-mediated exocytotic process.
Involvement of intracellular Ca
2+ stores in P-CTX-1B-
induced catecholamine release
In view of our previous evidence for a role of intracellular Ca
2+
stores in P-CTX-1B-evoked Ca
2+ rise (see Figure 2), we examined
the possible role of caffeine-sensitive Ca
2+ stores in mediating P-
CTX-1B-evoked catecholamine release. Pre-incubation of chro-
maffin cells with increasing concentrations of caffeine in a Ca
2+-
containing medium, prior to P-CTX-1B stimulation, resulted in a
significant inhibition of P-CTX-1B-induced catecholamine release
(Figure 5, black bars). Importantly, in bovine chromaffin cells,
caffeine alone did not promote catecholamine secretion (Figure 5,
white bars), as reported previously [14,18,19]. It should be noted
that caffeine induces an intracellular Ca
2+ increase in bovine
chromaffin cells that corresponds to a Ca
2+ release from internal
Brevenal Blocks P-CTX1B Effect
PLoS ONE | www.plosone.org 2 October 2008 | Volume 3 | Issue 10 | e3448Figure 1. P-CTX-1B induces sodium influx into chromaffin cells. Chromaffin cells loaded with cell permeable sodium-green (6 mM)
supplemented with 0.01% of pluronic acid for 45 min and washed before examination by time-lapse confocal microscopy at 5 min/frame. (A):
Sodium-green loaded chromaffin cells observed in the absence (upper single cell) and presence (bottom cells) of P-CTX-1B (50 nM) at various times
(indicated in minutes). Changes in the fluorescent intensity of sodium-green are displayed in pseudocolour. (Scale bar: 5 mm). (B) The curves show
the changes in fluorescence ratio (F/F0) of sodium-green as described in the materials and methods section in both control (empty circles) and P-CTX-
1B-treated (filled circles) cells. (C) The bar graph shows the peak fluorescent intensity change of sodium-green loaded chromaffin cells in the
following conditions: control; P-CTX-1B alone (50 nM); TTX (1 mM) and P-CTX-1B (50 nM); TTX alone (1 mM). Data are expressed as mean6SEM.
(Student t test, **p,0.01) Scale bar: 5 mm.
doi:10.1371/journal.pone.0003448.g001
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PLoS ONE | www.plosone.org 3 October 2008 | Volume 3 | Issue 10 | e3448stores of the ER [19]. Our result strongly suggests that internal
caffeine-sensitive Ca
2+ stores are indeed required for mediating the
secretagogue effect of P-CTX-1B.
Having established bovine chromaffin cells as a good model to
investigate the mechanism underpinning P-CTX-1B neurosecre-
tory effect, we explored ways to block this secretagogue activity.
Brevetoxin and P-CTX-1B share an identical binding site on
voltage-sensitive Na
+ channels (VSSC), called receptor-site 5
[20,21]. In view of the recent discovery of brevenal, a natural
compound from Karenia brevis found to selectively displace
brevetoxin from site 5 of the VSSC [22], we hypothesised that
brevenal could also act as a potent inhibitor of P-CTX-1B
stimulatory action. Pretreatment of chromaffin cells with increas-
ing concentrations of brevenal (in mM: 0, 0.01, 0.05, 0.1, 0.5, 1.5,
10) did not have any noticeable effect on catecholamine secretion
(Figure 6A). However, P-CTX-1B (10 nM) stimulatory effect was
inhibited in a dose-dependent manner by brevenal (Figure 6A).
This significant inhibitory effect exhibited an initial phase of
inhibition for nanomolar concentrations of brevenal, followed by a
less potent inhibitory phase for micromolar concentrations
(IC50,2 mM). This biphasic effect was accentuated by raising P-
CTX-1B concentration to 50 nM (Figure 6A). The inhibitory
effect of brevenal was reversible by simple washout (data not
shown). Importantly, brevenal did not significantly affect nicotine-
induced catecholamine secretion (Figure 6A). This demonstrates
that the ability of nicotinic acetylcholine receptors to respond to
nicotine stimulation was not modified by brevenal in chromaffin
cells. b-Naphtoyl-brevetoxin, another competitive inhibitor of
brevetoxin binding on VSSC was also tested in our system.
Similarly, b-naphtoyl-brevetoxin prevented P-CTX-1B-induced
catecholamine secretion without interfering with nicotine secreta-
gogue activity (Figure 6B).
Discussion
Voltage-sensitive Na
+ channels are transmembrane proteins
responsible for the depolarising phase of action potentials in
excitable cells [21]. These channels are targeted by several
neurotoxins, which alter their biophysical properties, physiological
regulation and thus the related functional activity. Our investiga-
tion reveals that P-CTX-1B promotes a TTX-sensitive long-
lasting cytosolic Na
+ increase in bovine chromaffin cells. This, in
turn, triggers an intracellular Ca
2+ increase responsible for eliciting
catecholamine secretion from chromaffin cells. This secretion is
strictly dependent on external Ca
2+, suggesting that a Ca
2+ influx
is required, and appears to be mediated by Ca
2+ stores, as it is
sensitive to caffeine treatment. P-CTX-1B is shown herein to be a
potent albeit slow-acting secretagogue for neuroendocrine cells.
The induced catecholamine secretion results from a Na
+-mediated
Ca
2+ entry through regulated exocytosis, as revealed by its potent
inhibition by BoNT/A. Finally, we show that both brevenal and b-
naphtoyl-brevetoxin prevent P-CTX-1B-induced catecholamine
secretion – a finding with ramification for future treatment of the
widespread human disease ciguatera.
Deciphering the various steps leading to P-CTX-1B-
induced neuronal secretion: initial Na
+ influx
Ciguatoxins bind to voltage-sensitive Na
+ channels with high
affinity [4,5,23]. These cyclic polyethers compounds modify Na
+
current by shifting the voltage-dependency of Na
+ channel
activation towards more negative values, and by partly suppressing
their inactivation [8,24]. There are a variety of functional
consequences to promoting such Na
+ influx in excitable cells:
trains of spontaneous action potentials, volume increase of nodal
region of frog myelinated nerve fibres [8,25,26], enhancement of
Figure 2. P-CTX-1B produces a transient Na
+-dependent cytosolic Ca
2+ increases in bovine chromaffin cells. (A) Optical sections of a
confocal-imaged chromaffin cell pre-loaded with fluo-3/AM following the addition of P-CTX-1B (10 nM) to a 2 mM Ca
2+-containing medium (time in
sec indicated in the figure). Scale bar: 10 mm. (B) Relative variation of fluo-3 fluorescence (F/F0) determined, as a function of time, in a Ca
2+-containing
medium (black curve, representative of n=12 cells) or in a Ca
2+-free medium added with 2 mM EGTA (red curve, representative of n=6 cells). (C)
Same experiment as in A, but chromaffin cells were pre-treated with TTX (1 mM for 15 min) prior to addition of P-CTX-1B to a Ca
2+-containing
medium. High K
+ was added to the medium after 2 min (last image). Scale bar: 10 mm. (D) Fluorescence variation showing that TTX abolishes the
ciguatoxin-induced fluorescence increase. High K
+-induced depolarization of the cell still produces a robust fluorescence increase.
doi:10.1371/journal.pone.0003448.g002
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terminals at the frog neuromuscular junction [9,25], spontaneous
activity in neuroblastoma cells [23], activation of the Na
+/Ca
2+
exchanger in the reversed mode followed by neurotransmitter
release from synaptosomes [13], and Ca
2+ mobilisation in
neuroblastoma cells [12]. It was therefore important to clarify
the effects of such a Na
+ channel activator on intracellular
concentrations of Na
+ and Ca
2+ and neurotransmitter release. In
the presence of ciguatoxins, large quantities of Na
+ are believed to
flow into cells during the depolarizing phase of spontaneous and/
or repetitive action potentials as a result of the partial inhibition of
voltage-sensitive Na
+ channel inactivation [8,27,28]. Such high
Na
+ concentration is compensated by a water influx, that can be
reversed or prevented using the hyperosmotic agent D-mannitol
[8,26]. Our results differ from those of Bidard et al. [23], in which
measurements of
22Na
+ in neuroblastoma cells indicated that
ciguatoxin could only promote detectable
22Na
+ increase only if it
acts in synergy with other voltage-sensitive Na
+ activators, such as
veratridine or batrachotoxin [23]. The requirement for co-
activation of voltage-sensitive Na
+ channels in promoting
intracellular Na
+ increase was confirmed with the use of
brevetoxin-3 combined to veratridine in chromaffin cells [29].
Figure 3. P-CTX-1B triggers a Ca
2+-dependent catecholamine
release via activation of voltage-sensitive Na
+ channels. (A)
Chromaffin cells, bathed in the presence (filled circles) or the absence
(empty circles) of 2 mM Ca
2+ were subjected to P-CTX-1B (10 nM),
before removal of an aliquot and assay of its catecholamine content by
fluorimetry. Mean amounts of secreted catecholamine (6S.E.M.) are
plotted as a percentage of the total content of the cells. P-CTX-1B
evokes a Ca
2+-dependent catecholamine secretion. (B) Chromaffin cells
were incubated for 30 min with different concentrations of P-CTX-1B,
either with (filled circles) or without (empty circles) external Ca
2+
(2 mM), before measurement of the amount of catecholamines. The
toxin-induced catecholamine secretion is dose-dependent. (C) Amount
of catecholamine secreted from chromaffin cells after 30 min exposure
to P-CTX-1B (10 nM), in a Ca
2+-containing (2 mM, black bars) or a Ca
2+-
free (white bars) medium, in the presence or in the absence of TTX
(1 mM).
doi:10.1371/journal.pone.0003448.g003
Figure 4. P-CTX-1B triggers SNARE-dependent catecholamine
release. Intact chromaffin cells which had been poisoned by
prolonged exposure to BoNT/A (66 nM) and control cells were exposed
to P-CTX-1B (10 nM) in a Ca
2+-containing medium (2 mM) before
measuring the amount of secreted catecholamines. The P-CTX-1B-
induced neurosecretion is impaired by BoNT/A. A representative graph
for two experiments carried out in quadruplicate is shown.
doi:10.1371/journal.pone.0003448.g004
Figure 5. Implication of Ca
2+ stores on ciguatoxin-evoked
release of catecholamines. Chromaffin cells were pre-treated
(20 min) with increasing concentrations of caffeine and subsequently
exposed (black bars) or not (white bars) to P-CTX-1B (10 nM), before
measuring the amount of secreted catecholamines. The P-CTX-1B-
induced catecholamine release is decreased following depletion of
internal caffeine-sensitive Ca
2+ stores. A representative graph for three
experiments carried out in quadruplicate is shown.
doi:10.1371/journal.pone.0003448.g005
Brevenal Blocks P-CTX1B Effect
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+
increase in neuronal cells through direct activation of voltage-
sensitive sodium channels at site 4 [30]. Our study, using confocal
imaging techniques, reveals a slow albeit robust Na
+ influx in
response to P-CTX-1B alone without requiring the synergistic
action of another activator. This Na
+ increase was almost totally
inhibited by TTX pre-treatment, providing compelling evidence
for the implication of voltage-sensitive Na
+ channels in this effect
as also shown in neuroblastoma cells [23]. These experiments were
conducted in a Ca
2+-free medium supplemented with EGTA to
avoid the Na
+/Ca
2+ exchange system to be activated in the
reversed mode, as it has been demonstrated previously [13]. This
Figure 6. Brevenal and b-naphtoyl-brevetoxin abolishes ciguatoxin-evoked release of catecholamines. Chromaffin cells were pre-
treated (15 min) with increasing concentrations of either brevenal (A)o rb-naphtoyl-brevetoxin (B) and subsequently exposed to indicated
concentrations of P-CTX-1B, nicotine or vehicle alone as indicated in the figure, before measuring the amount of secreted catecholamines. Data are
expressed as mean6SEM. Only P-CTX-1B-induced catecholamine release is blocked by brevenal and b-naphtoyl-brevetoxin pre-treatments.
Representative graphs for three experiments carried out in octoplicate are shown.
doi:10.1371/journal.pone.0003448.g006
Brevenal Blocks P-CTX1B Effect
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two methods used and the relatively short duration of the
experimental design used in Bidard et al. Indeed, initial rate of
22Na
+ uptake was only determined after 1 min during which little
Na
+ influx was observed in our hands [23].
P-CTX-1B promotes Ca
2+ influx coupled with Ca
2+ release
from the intracellular Ca
2+ stores
In chromaffin cells, P-CTX-1B-induced activation of voltage-
sensitive Na
+ channels produced a rise in cytosolic Ca
2+ detected
either in a Ca
2+-containing or a Ca
2+-free medium. The opening
of voltage-sensitive Na
+ channels has been reported to lead to
membrane depolarization and the consequent activation of
voltage-gated Ca
2+ channels [31] and to the activation of reverse
Na
+/Ca
2+ exchangers which extrudes Na
+ under pathophysiolog-
ical conditions [32]. Alternatively, the CTX-induced sodium
influx could simply reduce the sodium gradient that normally
drives the removal in intracellular Ca
2+ via the Na
+/Ca
2+
exchanger, allowing accumulation of Ca
2+ in the stores. The
combination of these effects may explain why a Ca
2+ increase was
recorded following the addition of P-CTX-1B. This transient Ca
2+
rise was TTX-sensitive and spatially restricted. This type of
localized Ca
2+ increase is classical in chromaffin cells where Ca
2+
stores such as those of the endoplasmic reticulum are segregated in
specialized region [33]. Therefore our results show that cytosolic
Ca
2+ transient increase results from the combination of a Ca
2+
influx into the cells and a Ca
2+ release from internal Ca
2+ stores, as
previously reported in chromaffin cells [14] and neuroblastoma
cells [12]. Following the intracellular rise in Ca
2+ level, the return
to basal level was not achieved in the presence of P-CTX-1B. This
suggests that P-CTX-1B initially induces a Ca
2+ influx closely
followed by a Ca
2+ release from intracellular Ca
2+ stores necessary
to maintain the level of secretion, as suggested by the inhibitory
effect obtained with caffeine pre-treatment. Importantly, an
alternative source of Ca
2+ entry through a store-operated
mechanism could be involved, as to help replenish intracellular
Ca
2+ stores in response to their full or partially Ca
2+ depletion
[34]. We demonstrate here that P-CTX-1B-induced activation of
voltage-sensitive Na
+ channels produced a rise in cytosolic Ca
2+ in
chromaffin cells detected either in a Ca
2+-containing or a Ca
2+-
free medium, suggesting that Na
+ influx may directly couple to
intracellular calcium release.
P-CTX-1B promotes the SNARE-dependent exocytosis of
catecholamine-containing secretory vesicles
In this study, we show that P-CTX-1B is a potent secretagogue
for chromaffin cells which is highly dependent on external Ca
2+.
This suggests that the activation of voltage-sensitive Na
+ channels
produces a Ca
2+ influx necessary for triggering neurosecretion.
The evoked catecholamine secretion results from the initial
activation of voltage-sensitive Na
+ channels by P-CTX-1B, since
it was abolished by TTX pre-treatment. This catecholamine
secretion occurs through regulated exocytosis of catecholamine
containing large dense core vesicles, as revealed by its sensitivity to
the cleavage of SNAP-25 by BoNT/A.
Finally, the secretagogue activity of P-CTX-1B requires
intracellular Ca
2+ stores, since pre-emptying the stores with
caffeine significantly decreased its stimulatory effect. Bearing in
mind that direct stimulation of Ca
2+ stores is unable to trigger
catecholamine secretion [35], our result demonstrate that Ca
2+
from internal stores is necessary to potentiate catecholamine
secretion probably by inducing a Ca
2+ influx through a store-
operated entry pathway [36].
Brevenal and b-naphtoyl-brevetoxin prevent P-CTX-1B
stimulatory effect without affecting nicotinic response
Our result shows that both brevenal and b-naphtoyl-brevetoxin
are capable of blocking the stimulatory effect of P-CTX-1B, at
physiologically relevant concentrations, demonstrating that both
compounds act as functional antagonists for ciguatoxin. Brevenal
is a non-toxic 8-fused ring polyether natural compound produced
by K. brevis that was shown to successfully displace [
3H]-PbTx-3
from receptor site 5 of VSSC [37]. Moreover, brevenal and
gambierol have recently been shown to be potent antagonists of
PbTx-2-induced Ca
2+ influx in neurons [38]. The relevance of the
competitive nature of brevenal towards brevetoxin has been
argued on the basis of structural differences [39]. However,
brevenal has been demonstrated to be a potent functional
antagonist that confers protection from brevetoxin-induced
lethality in fish [37,40] and in an asthma model in sheep [41].
Brevenal is a lead compound for the development of treatment for
cystic fibrosis and neurotoxic shellfish poisoning. Our results
strongly suggest that brevenal could be a molecule of choice for the
potential treatment of ciguatera.
In conclusion, our results provide conclusive evidence that,
following ciguatoxin treatment, the slow increase in intracellular
Na
+ through VSSC leads to an influx of Ca
2+ relayed by activation
of a Ca
2+-induced Ca
2+ release which significantly contributes to
the secretion of catecholamines. Ciguatera is a dangerous
condition especially considering that, with the global tropical
fisheries markets, symptoms of ciguatera are starting to appear well
outside the endemic regions, eg. in Europe [3]. There is no known
cure for ciguatera condition, although mannitol can provide
limited symptomatic relief (1). A full understanding of the
molecular mechanisms initiated by ciguatoxin binding to volt-
age-sensitive Na
+ channels through to the release of neurotrans-
mitter is necessary to develop new therapies for this type of
channelopathy. Our study demonstrates that brevenal, a natural
compound extracted from Karenia brevis, can potently inhibit
ciguatoxin’s stimulatory effect on exocytosis therefore providing
the basis of the first potential specific treatment of ciguatera.
Materials and Methods
Cell culture
Bovine chromaffin cells were prepared from adrenal glands and
maintained as primary cultures, following procedures previously
described [15]. Within 2-3 days, cells were incubated in the
presence or in the absence of botulinum type A neurotoxin
(BoNT/A, 66 nM) in a low ionic strength buffer (37uC, 24 hours)
to facilitate BoNT/A uptake [42]. Chromaffin cells were then
returned to their original medium for 24 hours before starting
experiments.
Drugs
P-CTX-1B was extracted and highly purified from the Pacific
moray-eel Gymnothorax javanicus [43,44]. The dry toxic extracts
were dissolved in ethanol, and the solution was divided into several
samples. The ethanol was then evaporated. Samples were kept dry
at 220uC and diluted with external solutions immediately before
experiments. Brevenal and PbTx-2 were isolated from cultures of
K. brevis (Wilson Clone) [40] and aliquoted into 0.5 mg vials and
stored dry at 220uC, b-naphtoyl-brevetoxin was synthesized from
PbTx-2 [45], aliquoted into 0.5 mg vials and stored dry at 220uC.
Tetrodotoxin (TTX) was purchased from Sigma (St Louis, MO,
USA); Fluo-3/AM and sodium green/AM were purchased from
Molecular Probes (Invitrogen), caffeine from Sigma Chemical Co.
(Dorset, UK). BoNT/A was purified as previously described [46],
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(2-hydroxyethyl)-1-piperazineethanesulfonic acid ) (HEPES) buffer
(pH 7.4) at 220uC.
Confocal microscopy
Chromaffin cells were loaded by incubation (30–45 min, room
temperature) with either fluo-3/AM or sodium green/AM in
Krebs-Ringer solution. After washing the cells with a dye-free
solution, the coverslips were placed on the stage of the microscope
and imaged by confocal microscopy. A Sarastro 2000 or a Zeiss
510 META confocal laser scanning microscope (Molecular
Dynamics, USA) was used. The aperture setting of the confocal
pinhole was 100 mm. Cells were either visualized using a 406or a
606 water immersion objective (Zeiss 0.75 and 0.9 numerical
aperture respectively). The 488 nm band of the Argon ion laser
was used for excitation and the emitted light was collected through
a 510 nm long-pass. All experiments were performed at room
temperature and time series of cell confocal sections were acquired
(using a time-lapse mode) with a frame interval of 5 s for fluo-3/
AM and 5 min for sodium green/AM. Sections were collected
using a standard scanning mode format of 5126512 pixels. The
fluo-3/AM or sodium green/AM loaded cells were presented
using a pseudocolor scale. The index of fluorescence variation was
calculated and presented as F/F0, where F0 is the initial cell
fluorescence and F the monitored cell fluorescence.
Measurement of catecholamine secretion
The catecholamine secretion was quantified as previously
described [14]. Briefly, chromaffin cells were washed once with
HEPES-buffered saline solution containing (in mM) 145 NaCl, 5
KCl, 1.2 NaH2PO4, 10 glucose, 20 HEPES (pH 7.4), and
processed in quadruplicate. Aliquots (200 ml) of the medium were
removed at the end of each experiment, and cells were lysed with
Triton x-100 (1%, v/v). Both set of samples were assayed
fluorimetrically for catecholamine content. Amounts released were
expressed as a percent of the total content of catecholamines
present in the cells [18]. Data were representative of experiments
carried out in quadruplicate and performed at least 3 times.
Statistical analysis
Data analysis was carried out using Student’s t test. All
experiments were performed at least 3 times. Values were
expressed as mean6SEM and data were considered significant
at *p,0.05 and **p,0.01.
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